• February 1, 2017

    Most emerging diseases come from animals (zoonosis). Therefore, surveillance needs to keep an eye on viruses and other microorganisms that could be transmitted to humans, acquiring the capability to spread among people. Ilaria Capua, director of the One Health Excellence Centre at the Emerging Pathogens Institute of the University of Florida, USA, recommends not letting our guard down.

  • October 24, 2016

    While USA recommend universal flu vaccination for 6 months age, some European countries have different strategies, targeting only children with chronic diseases. Susanna Esposito, professor of Paediatrics at the University of Milan, Italy and president of WAIDID (World Association for Infectious Diseases) advocates for a wider coverage against influenza in healthy children as well.

  • October 11, 2016

    Preparedness is also made of vigilance towards new infectious threats. Professor Bert Niesters from the University of Groningen, in the Netherlands, tells ASSET an example of spontaneous cooperation among 42 laboratories from more than 20 countries in Europe in facing an emerging, dangerous infection: enterovirus D68 respiratory epidemic in 2014-2015. That experience is now going on, taking the name of EUROTYPE.

  • September 21, 2016

    While the number of human cases of H7N9 bird flu is rising in China, and H5N1 is a persistent threat, different strategies of prevention are being considered. In a “one health” approach, vaccination of poultry is one of the possibilities, according to Ivan Hung, Clinical Associate Professor and Honorary Consultant in the Department of Medicine at the Queen Mary Hospital of the University of Hong Kong.

  • June 13, 2016

    One of the main source of distrust towards public health authorities is the suspect of hidden connections with the pharmaceutical industry, but, in case of a severe pandemic, an adequate supply of antivirals and vaccines is essential. ASSET asked Norman Begg, GSK Vice President, Head of Scientific Affairs and Public Health, Vaccines, what kind of agreements exist for Public Health Emergencies of International Concern (PHEIC) or of a pandemic, between big pharma and WHO. The answer for the two situations is not the same.

ASSET Analytics

Gender Platform

Best Practice Platform

Gender Platform

Best Practice Platform

The third issue of the ASSET Paper Series focuses on some highly delicate topics that lie at the intersection of science, ethics, politics, and economics. In the first article of the collection, Donato Greco, epidemiologist and public health expert, discusses about the role and the management of national borders when dealing with both the spread of an infectious disease and the flow of migrants or refugees, citing the recent EU decision on such a matter.

Last January, the scientific journal Nature published a news about scientists who do research funded by the Gates Foundation, who are not allowed to publish their work in those journals that do not comply with the Foundation’s open-access policy. This is the case of important publications such as NatureScience and the New England Journal of Medicine (NEJM).

Immunization rates in Italy are decreasing at a worrying trend: international targets for measles eradication and safety thresholds in childhood vaccination are vanishing. Authorities, doctors and families are concerned that a coverage below 86% for MPR (measles, parotitis and rubella) vaccine can impair herd immunity, putting younger babies, immunocompromised people and not-responders at risk.

Work Packages

Dialogue & Participation
Study & Analysis
Action Plan Definition
Citizen Consultation
Mobilization and Mutual Learning
Policy Watch
Communication
Evaluation
Legacy
Management

Partners

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Effective communication in outbreak management: development of an evidence-based tool for Europe
Developing the framework for an epidemic forecast infrastructure
European monitoring of excess mortality for public health action
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Medical ecosystem – personalized event-based surveillance
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence